NeRRe Therapeutics raises £20 million in a Series B2 financing round

by Columbus Venture Partners

The financing round involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners andexisting investors Advent Life Sciences, Fountain Healthcare ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Nazca Capital Acquires a Majority Stake ...

by Nazca Capital

MAD creates, produces and distributes large-scale immersive cultural e...

Photos Stream